1. Home
  2. INBK vs CCCC Comparison

INBK vs CCCC Comparison

Compare INBK & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Internet Bancorp

INBK

First Internet Bancorp

HOLD

Current Price

$23.81

Market Cap

179.3M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.92

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INBK
CCCC
Founded
1999
2015
Country
United States
United States
Employees
355
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.3M
185.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
INBK
CCCC
Price
$23.81
$2.92
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$23.25
$12.20
AVG Volume (30 Days)
50.7K
2.5M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
1.06%
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
$279.34
N/A
Revenue Next Year
$12.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$17.05
$1.21
52 Week High
$28.51
$3.82

Technical Indicators

Market Signals
Indicator
INBK
CCCC
Relative Strength Index (RSI) 61.60 53.72
Support Level $23.52 $2.30
Resistance Level $24.85 $3.20
Average True Range (ATR) 0.94 0.22
MACD -0.08 -0.02
Stochastic Oscillator 61.69 58.09

Price Performance

Historical Comparison
INBK
CCCC

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: